Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126746 · ClinicalTrials.gov registry record
Clinical Trials in Organ Transplantation Extension Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 501
- Enrollment target
NCT04126746 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 501 participants.
The verdict
NCT04126746 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 501 participants
- Enrollment target
Study Summary
The purpose of the study is to continue to follow subjects who were enrolled in the CTOT-20 CLAD Phenotypes study. Subjects will provide clinical data and complete quality of life questionnaires that will be used to determine the clinical factors associated with the development of Chronic Lung Allograft Dysfunction (CLAD) after lung transplant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2024-08-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04126746
The ClinicalTrials.gov registry entry for NCT04126746 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 501 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04126746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04126746 about?
NCT04126746 is a clinical study titled "Clinical Trials in Organ Transplantation Extension Study". The purpose of the study is to continue to follow subjects who were enrolled in the CTOT-20 CLAD Phenotypes study. Subjects will provide clinical data and complete quality of life questionnaires that will be used to determine the clinical factors associated with the development of Chronic Lung Allog...
What is the current status of trial NCT04126746?
This trial is currently completed. The enrollment target is 501 participants. The study started on 2019-12-17. Estimated completion is 2024-08-26.
Who is sponsoring clinical trial NCT04126746?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.